BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19546437)

  • 1. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
    van de Loosdrecht AA; Alhan C; Béné MC; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Homburg CH; Ireland R; Jansen JH; Kern W; Malcovati L; Te Marvelde JG; Mufti GJ; Ogata K; Orfao A; Ossenkoppele GJ; Porwit A; Preijers FW; Richards SJ; Schuurhuis GJ; Subirá D; Valent P; van der Velden VH; Vyas P; Westra AH; de Witte TM; Wells DA; Loken MR; Westers TM
    Haematologica; 2009 Aug; 94(8):1124-34. PubMed ID: 19546437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.
    Westers TM; Ireland R; Kern W; Alhan C; Balleisen JS; Bettelheim P; Burbury K; Cullen M; Cutler JA; Della Porta MG; Dräger AM; Feuillard J; Font P; Germing U; Haase D; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Ogata K; Orfao A; Porwit A; Psarra K; Richards SJ; Subirá D; Tindell V; Vallespi T; Valent P; van der Velden VH; de Witte TM; Wells DA; Zettl F; Béné MC; van de Loosdrecht AA
    Leukemia; 2012 Jul; 26(7):1730-41. PubMed ID: 22307178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
    Porwit A; Béné MC; Duetz C; Matarraz S; Oelschlaegel U; Westers TM; Wagner-Ballon O; Kordasti S; Valent P; Preijers F; Alhan C; Bellos F; Bettelheim P; Burbury K; Chapuis N; Cremers E; Della Porta MG; Dunlop A; Eidenschink-Brodersen L; Font P; Fontenay M; Hobo W; Ireland R; Johansson U; Loken MR; Ogata K; Orfao A; Psarra K; Saft L; Subira D; Te Marvelde J; Wells DA; van der Velden VHJ; Kern W; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Jan; 104(1):27-50. PubMed ID: 36537621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.
    Xu F; Li X; Chang CK; Guo J; Wu LY; He Q; Zhang Z; Zhu Y; Gu SC; Shi WH; Song LX; Su JY; Zhou LY; Zhang X; Wu D
    PLoS One; 2014; 9(2):e88706. PubMed ID: 24558415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
    van de Loosdrecht AA; Kern W; Porwit A; Valent P; Kordasti S; Cremers E; Alhan C; Duetz C; Dunlop A; Hobo W; Preijers F; Wagner-Ballon O; Chapuis N; Fontenay M; Bettelheim P; Eidenschink-Brodersen L; Font P; Johansson U; Loken MR; Te Marvelde JG; Matarraz S; Ogata K; Oelschlaegel U; Orfao A; Psarra K; Subirá D; Wells DA; Béné MC; Della Porta MG; Burbury K; Bellos F; van der Velden VHJ; Westers TM; Saft L; Ireland R
    Cytometry B Clin Cytom; 2023 Jan; 104(1):77-86. PubMed ID: 34897979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of bone marrow cells immunophenotypic study by flow cytometry in diagnosing myelodysplastic syndrome].
    Czyz A; Dworacki G; Komarnicki M
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():354-63. PubMed ID: 18688206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?
    Cremers EM; Alhan C; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):14-21. PubMed ID: 25659726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of flow cytometry in diagnostics of myelodysplastic syndromes--beyond the WHO 2008 classification.
    Porwit A
    Semin Diagn Pathol; 2011 Nov; 28(4):273-82. PubMed ID: 22195405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.
    van de Loosdrecht AA; Westers TM; Westra AH; Dräger AM; van der Velden VH; Ossenkoppele GJ
    Blood; 2008 Feb; 111(3):1067-77. PubMed ID: 17971483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-color CD34⁺ progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia.
    Tang G; Jorgensen LJ; Zhou Y; Hu Y; Kersh M; Garcia-Manero G; Medeiros LJ; Wang SA
    Leuk Res; 2012 Aug; 36(8):974-81. PubMed ID: 22626984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry in myelodysplastic syndromes: report from a working conference.
    Loken MR; van de Loosdrecht A; Ogata K; Orfao A; Wells DA
    Leuk Res; 2008 Jan; 32(1):5-17. PubMed ID: 17576013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
    Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
    Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of flow cytometry in myelodysplastic syndromes.
    Loken MR; Wells DA
    J Natl Compr Canc Netw; 2008 Oct; 6(9):935-41. PubMed ID: 18926102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.
    Burbury KL; Westerman DA
    Leuk Lymphoma; 2014 Apr; 55(4):749-60. PubMed ID: 23808833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
    Shameli A; Dharmani-Khan P; Luider J; Auer I; Shabani-Rad MT
    Cytometry B Clin Cytom; 2021 Sep; 100(5):574-589. PubMed ID: 33369070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.